β³ Fetching live dividend data...
Home βΊ Calculator βΊ SGRY Dividend Calculator 2026
Surgery Partners, Inc. Β· NASDAQ
Price: $13.68 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in SGRY β $2.31M in 10 years Β· $167,457.75/month
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open SGRY position with:
Real after-tax yield depends on where you live and how you hold SGRY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 14.62% | 11.82% | $1,462 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 12.43% | 9.63% | $1,243 / yr |
| πΊπΈ US Taxable (20%) | 20% | 11.70% | 8.90% | $1,170 / yr |
| π¬π§ UK ISA | 0% | 14.62% | 11.82% | $1,462 / yr |
| π¬π§ UK Taxable | 8.75% | 13.34% | 10.54% | $1,334 / yr |
| π¨π¦ TFSA | 0% | 14.62% | 11.82% | $1,462 / yr |
| π¨π¦ CA Taxable | 25% | 10.96% | 8.16% | $1,097 / yr |
| π¦πΊ Super (pension) | 15% | 12.43% | 9.63% | $1,243 / yr |
| π¦πΊ AU Taxable | 30% | 10.23% | 7.43% | $1,023 / yr |
| π©πͺ DE Taxable | 26.375% | 10.76% | 7.96% | $1,076 / yr |
| π«π· FR Taxable | 30% | 10.23% | 7.43% | $1,023 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
SGRY pays quarterly β 4 times per year. Next ex-div: TBD.
How SGRY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SGRY sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-05 | 11,670 | $13.71 | $160.0K | ||
| A-Award | 2026-06-05 | 11,670 | $13.71 | $160.0K | ||
| A-Award | 2026-06-05 | 11,670 | $13.71 | $160.0K | ||
| A-Award | 2026-06-05 | 11,670 | $13.71 | $160.0K | ||
| A-Award | 2026-06-05 | 11,670 | $13.71 | $160.0K | ||
| A-Award | 2026-06-05 | 11,670 | $13.71 | $160.0K | ||
| A-Award | 2026-06-05 | 11,670 | $13.71 | $160.0K | ||
| Sale | 2026-03-13 | 3,469 | $12.83 | $44.5K | ||
| Sale | 2026-03-13 | 3,657 | $12.54 | $45.9K | ||
| Sale | 2026-03-16 | 8,867 | $12.50 | $110.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SGRY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β